@misc{indiciae90e497c2326f,
  title = {PRMT5 inhibition preferentially targets MYCN-amplified neuroblastoma via altered transcriptional and splicing programmes regulating key cancer cell fitness pathways.},
  author = {Bojko, J. and Kollareddy, M. and Szemes, M. and Bellamy, J. and Poon, E. and Moukachar, A. and Legge, D. and Vincent, E. E. and Jones, N. and Malik, S. and Greenhough, A. and Paterson, A. and Park, J. H. and Gallacher, K. and Chesler, L. and Malik, K.},
  year = {2024},
  doi = {10.1101/2024.02.28.582087},
  url = {https://www.biorxiv.org/content/10.1101/2024.02.28.582087v1},
  note = {Source identifier: 10.1101/2024.02.28.582087}
}